NovaTero BioAg
NovaTero BioAg develops and sells Rootella BR and Rootella BR Ultra, Brazil's only registered arbuscular mycorrhizal fungi (AMF) inoculants, serving commercial soybean, corn, wheat, bean, rice, coffee, and potato farmers with biological seed treatments that improve phosphorus absorption and crop yields.
- Company typePrivate
- Founded-
- HeadquartersJoinville, Brazil
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What NovaTero BioAg does
NovaTero BioAg (legal entity HS2M Comércio Imp e Exp de Insumos Agrícolas LTDA) is a Brazilian agtech startup founded in 2015 and headquartered in Joinville, Santa Catarina. The company develops and commercializes Rootella BR, Brazil's first and only registered inoculant based on arbuscular mycorrhizal fungi (AMF), authorized by the Ministry of Agriculture since 2018. The product line includes the standard Rootella BR (2M+ active propagules per hectare, applied at 120g/hectare for seed treatment) and Rootella BR Ultra, a concentrated powder formulation containing at least 167,000 Rhizophagus intraradices propagules per gram. The technology is built on proprietary strains selected over 25+ years of research, with the fungi forming symbiotic associations with plant roots to enhance phosphorus absorption, expand root reach, improve drought resilience, and aid recovery of degraded soils.
The company serves commercial grain, pulse, and specialty crop producers across southern and southeastern Brazil (Rio Grande do Sul, Santa Catarina, Paraná, and Minas Gerais), targeting soybean, corn, wheat, beans, rice, coffee, and potato applications. NovaTero BioAg employs a hybrid go-to-market model combining a distributor/reseller network (with an active 'Quero revender' recruitment funnel), direct sales through commercial agents targeting larger farms, and an agronomist/consultant channel. Marketing is content-driven, relying on a substantial agricultural blog, downloadable technical resources, LinkedIn presence, agricultural media appearances, and field day demonstrations.
The business generates revenue through one-time unit sales of inoculant products, with documented field-trial outcomes of 5-35% productivity gains, ~50% average phosphorus fertilizer savings, and R$422-R$1,660/hectare economic uplift. With only 6-8 employees and no disclosed external funding, NovaTero BioAg operates as a lean, founder-led private company (co-founders Bernardo Arnaud as Chairman and Rodrigo Moreira as Commercial Director), concentrated exclusively on the Brazilian market where it holds an exclusive regulatory position.
NovaTero BioAg firmographics
Firmographics- Name
- NovaTero BioAg
- Legal name
- HS2M Comércio Imp e Exp de Insumos Agrícolas LTDA
- Website
- https://rootellabr.com.br
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- NovaTero BioAg develops and sells Rootella BR and Rootella BR Ultra, Brazil's only registered arbuscular mycorrhizal fungi (AMF) inoculants, serving commercial soybean, corn, wheat, bean, rice, coffee, and potato farmers with biological seed treatments that improve phosphorus absorption and crop yields.
- Ownership category
- akta.pro rank
NovaTero BioAg industry classification
Industry- Product category
- Agricultural Biologicals (Mycorrhizal Inoculants)
- SIC
- Agricultural Chemicals (2870)
- akta.pro primary industry
- Seed Inoculants & Biological Seed Enhancers (Rhizobia, Mycorrhizae, PGPR) (AFABAFAJ)
- akta.pro secondary industries
- Biological Seed Treatments & Inoculants (within Biologicals) (AFABAEAL), Biofertilizers & Microbial Inoculants (IMAEAEAG), Biostimulant-Enhanced Fertilizers (Humic/Fulvic, Amino Acids, Seaweed Blends) (AFABACAK)
Keywords
Where NovaTero BioAg is headquartered
LocationHeadquarters
- HQ city
- Joinville
- HQ country
- Brazil
- HQ region
- Latin America
Offices1 record
Markets served
NovaTero BioAg business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
Revenue model
- Rootella BR Product Sales: Sales of mycorrhizal inoculant products (Rootella BR and Rootella BR Ultra) to agricultural producers across Brazil. Products are applied via seed treatment at 120g per hectare. Revenue derived from direct product sales to distributors, resellers, and commercial farmers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Rootella BR - Standard mycorrhizal inoculant for seed treatment |
| Unit Pricing | Pay-as-you-go | Rootella BR Ultra - Concentrated powder formulation |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
NovaTero BioAg product offering
Product offeringCore offering
NovaTero BioAg develops and manufactures biological agricultural inoculants based on arbuscular mycorrhizal fungi (AMF) under the Rootella BR brand. The flagship Rootella BR, and the more concentrated Rootella BR Ultra, are applied as a seed treatment at 120 grams per hectare to enhance root development, improve phosphorus absorption, and increase crop productivity and resilience. The inoculant is the only AMF-based product registered in Brazil and is sold to commercial farmers and agribusinesses.
Product overview
NovaTero BioAg offers a focused portfolio of biological agricultural inputs centered on mycorrhizal inoculants. The company provides two products: Rootella BR (the primary product) and Rootella BR Ultra (a higher-concentration formulation). Both are biological inoculants composed of arbuscular mycorrhizal fungi (AMF) that form symbiotic relationships with plant roots to enhance nutrient absorption, increase root system development, improve crop resilience to environmental stress, and aid in degraded soil recovery. The products are distributed as powders for seed treatment and are certified for organic agriculture.
Differentiator
Problem solved
Functional benefit
Brands
- Rootella BR: Mycorrhizal inoculant with high concentration of vigorous endomycorrhizae, containing over 2 million active propagules per hectare. The only arbuscular mycorrhizal fungi-based inoculant registered in Brazil.
- Rootella BR Ultra
Products and services
- Rootella BR Rootella BR is NovaTero BioAg's flagship mycorrhizal inoculant, a powder-based biological input containing arbuscular mycorrhizal fungi (AMF) spores applied as a seed treatment at 120 grams per hectare. It is designed for commercial farmers producing soybean, corn, wheat, rice, beans, and sugarcane, and is documented to deliver 5–35% productivity gains and up to 50% phosphorus fertilizer savings, with more than 74,000 hectares treated since launch. It is the only AMF-based inoculant registered in Brazil.
- Rootella BR Ultra Rootella BR Ultra is a more concentrated version of NovaTero BioAg's Rootella BR mycorrhizal inoculant, offering a higher AMF propagule density per gram of product. It is also applied as a seed treatment and is targeted at the same commercial farmer and agribusiness customers in Brazil seeking to enhance root development, phosphorus uptake, and crop yields.
Quantifiable outcome
- 74,000+ hectares treated with Rootella BR in 3 years
- +6 more outcomes
Companies that use NovaTero BioAg
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles2 records
NovaTero BioAg technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
NovaTero BioAg partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Expansion highlights5 records
NovaTero BioAg competitors and assessment
Company assessmentRegional players
- Bioceres Crop Solutions: Argentina-based provider of agricultural biological and specialty inputs for South American row crops. Comparable as a regional Latin American biologicals player targeting soybean, corn, and wheat farmers with similar product categories.
Broad incumbents
- Novonesis (formerly Novozymes): Global leader in biological solutions with extensive agricultural microbial portfolio. Comparable as a major biological inputs incumbent competing in the broader agricultural biologicals space, including soil and crop health products that overlap with mycorrhizal inoculants.
- Lallemand Plant Care: Canadian subsidiary of Lallemand Inc. producing biological plant care products including inoculants and biostimulants. Comparable as an established biological-inputs player with overlapping product categories in agriculture, though broader and more international than NovaTero.
- Koppert Biological Systems: Dutch global leader in biological crop protection and natural pollination. Comparable as an established biologicals player with adjacent product lines (biostimulants, soil health) relevant to NovaTero's mycorrhizal inoculant market.
- Bayer Crop Science: Global agrochemical giant with growing biologicals portfolio and significant Brazilian presence. Comparable as a broad incumbent whose biological offerings compete in the same farmer channels as NovaTero's mycorrhizal inoculant in Brazil.
- Valent BioSciences: U.S.-based subsidiary of Sumitomo Chemical Company producing biorational and agricultural biological products. Comparable as a larger established biologicals producer with overlapping crop input categories, though broader portfolio and global scale.
- Corteva Agriscience: Global agricultural input company with a biologicals portfolio including seed-applied technologies. Comparable as a broad incumbent in row-crop biological inputs with established Brazilian distribution and farmer relationships.
Direct peers
- Symborg: Spanish agtech offering mycorrhizal inoculants and other biological inputs for agriculture. Directly comparable to NovaTero in the AMF mycorrhizal space, with broader international footprint producing similar products for crop producers.
- Groundwork BioAg: Israel-based company developing mycorrhizal inoculant products for row crops. Directly comparable to NovaTero as a specialist in AMF-based biological seed treatments, with similar product positioning and technology stack.
Emerging players
- Indigo Ag: U.S.-based agtech developing microbial seed treatments for row crops. Comparable as an emerging microbial inoculant player targeting similar crops (soybean, corn, wheat) and offering farmers biological alternatives to traditional inputs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
NovaTero BioAg social profiles
Digital presenceNovaTero BioAg financial estimates
Financial estimateRevenue estimate
Valuation estimate
NovaTero BioAg leadership team
Management profileNumber of profiles
Profiles7 records
NovaTero BioAg funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NovaTero BioAg M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NovaTero BioAg
What does NovaTero BioAg do?
NovaTero BioAg develops and manufactures biological agricultural inoculants based on arbuscular mycorrhizal fungi (AMF) under the Rootella BR brand. The flagship Rootella BR, and the more concentrated Rootella BR Ultra, are applied as a seed treatment at 120 grams per hectare to enhance root development, improve phosphorus absorption, and increase crop productivity and resilience. The inoculant is the only AMF-based product registered in Brazil and is sold to commercial farmers and agribusinesses.
Is NovaTero BioAg a public or private company?
NovaTero BioAg is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was NovaTero BioAg founded?
NovaTero BioAg was founded in -1. It employs 1 to 10 people.
Where is NovaTero BioAg based?
NovaTero BioAg is headquartered in Joinville, Brazil, in the Latin America region.
How does NovaTero BioAg make money?
One revenue line is on record: rootella BR Product Sales.
Who are NovaTero BioAg's main competitors?
Bioceres Crop Solutions is listed as a regional player. Broad incumbents are Novonesis (formerly Novozymes), Lallemand Plant Care, Koppert Biological Systems, Bayer Crop Science, Valent BioSciences and Corteva Agriscience. Direct peers are Symborg and Groundwork BioAg. Indigo Ag is listed as an emerging player.
Does NovaTero BioAg have an API?
No public API is recorded for NovaTero BioAg.
What industry is NovaTero BioAg in?
NovaTero BioAg's product category is Agricultural Biologicals (Mycorrhizal Inoculants). Its primary akta.pro industry code is AFABAFAJ, Seed Inoculants & Biological Seed Enhancers (Rhizobia, Mycorrhizae, PGPR), with a secondary code of AFABAEAL, Biological Seed Treatments & Inoculants (within Biologicals). Its SIC code is 2870.